mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
0.28 |
0.05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.06 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |